Antispasmodic Tablet Franchise in Ahmedabad

Otiprol 40 Tablet Supplier in Mumbai

Gastrointestinal Spasm Relief Tablet Distributor in Delhi

Otilonium Bromide Tablet Manufacturer in Bangalore

IBS & Abdominal Pain Tablet Stockist in Hyderabad
Antispasmodic Tablet Exporter in Chandigarh

Home/Products /otilonium-bromide-40mg-tablet

Otiprol 40 Tablet

Composition : Otilonium Bromide (40mg) Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹0/-

Otiprol 40 Tablet contains Otilonium Bromide 40 mg, a peripherally acting smooth muscle relaxant that targets the gastrointestinal tract to reduce spasms, relieve pain, and improve bowel motility without affecting normal digestive functions.

Clinically, Otilonium Bromide is indicated for irritable bowel syndrome (IBS), functional gastrointestinal disorders, and abdominal cramping, where excessive smooth muscle contraction causes discomfort and bloating. The drug is effective in both acute and chronic episodes, improving patient quality of life.

The tablet formulation ensures accurate dosing, consistent bioavailability, and predictable therapeutic outcomes, making it suitable for gastroenterology clinics, hospitals, and specialty pharmacies. Oral administration allows convenient dosing and high patient adherence.

Otiprol 40 Tablet helps in relieving abdominal cramps, reducing bloating, and supporting normal bowel function. Its proven safety and efficacy profile makes it a trusted antispasmodic therapy option under proper medical supervision.

Read More

About the Product

Otiprol 40 Tablet contains Otilonium Bromide 40 mg, a peripherally acting smooth muscle relaxant that targets the gastrointestinal tract to reduce spasms, relieve pain, and improve bowel motility without affecting normal digestive functions.

Clinically, Otilonium Bromide is indicated for irritable bowel syndrome (IBS), functional gastrointestinal disorders, and abdominal cramping, where excessive smooth muscle contraction causes discomfort and bloating. The drug is effective in both acute and chronic episodes, improving patient quality of life.

The tablet formulation ensures accurate dosing, consistent bioavailability, and predictable therapeutic outcomes, making it suitable for gastroenterology clinics, hospitals, and specialty pharmacies. Oral administration allows convenient dosing and high patient adherence.

Otiprol 40 Tablet helps in relieving abdominal cramps, reducing bloating, and supporting normal bowel function. Its proven safety and efficacy profile makes it a trusted antispasmodic therapy option under proper medical supervision.

Common side effects may include mild nausea, dry mouth, dizziness, or constipation. Rarely, allergic reactions or severe hypotension may occur.

Otiprol 40 Tablet is indicated for the management of abdominal pain, cramping, bloating, and discomfort associated with irritable bowel syndrome (IBS) and other functional gastrointestinal disorders, as prescribed by a healthcare professional.

Use Otiprol 40 Tablet under medical supervision. Caution is advised in patients with severe hypotension or known hypersensitivity to Otilonium Bromide. Do not exceed the prescribed dose. Seek immediate medical attention if severe allergic reactions or persistent gastrointestinal symptoms occur.

Store in a cool, dry place below 25°C. Protect from moisture and direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation